Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Morein

Showing results (81-90 of 163) with videos related to

Pageof 17
Sort By:
Nature|March 4, 1984
Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped virusesB Morein, B Sundquist, S Höglund, et al.
Veterinary Immunology and Immunopathology|April 1, 1988
Detection of B and T cells, with lectins or antibodies, in healthy and bovine leukemia virus-infected cattleC Fossum, A Burny, D Portetelle, et al.
Veterinary Immunology and Immunopathology|November 1, 1979
Helix pomatia a hemagglutinin, a surface marker for bovine T-lymphocytesB Morein, U Hellström, L Axelsson, et al.
Zentralblatt Fur Veterinarmedizin. Reihe B. Journal of Veterinary Medicine. Series B|June 1, 1991
ISCOM of BHV-1 envelope glycoproteins protected calves against both disease and infectionM Merza, S Tibor, L Kucsera, et al.
Vaccine|April 1, 1989
Formation and characterization of FeLV ISCOMsL Akerblom, K Strömstedt, S Hoglund, et al.
Veterinary Immunology and Immunopathology|November 1, 1996
Novel adjuvants and vaccine delivery systemsB Morein, M Villacrés-Eriksson, A Sjölander, et al.
Scandinavian Journal of Immunology|September 1, 1992
Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus iscomsM Villacres-Eriksson, M Bergström-Mollaoglu, H Kåberg, et al.
Vaccine|July 27, 1999
Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretionsJ Ekström, K F Hu, K L Bengtsson, et al.
Biotechnology Therapeutics|January 1, 1993
HIV experimental vaccines based on the iscom technology using envelope and GAG gene productsL Akerblom, P Nara, N Dunlop, et al.
Vaccine|December 31, 1997
Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicityB Rönnberg, M Fekadu, S Behboudi, et al.
Pageof 17

Showing results (81-90 of 163) with videos related to

Sort By:
Pageof 17
Nature|March 4, 1984
Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped virusesB Morein, B Sundquist, S Höglund, et al.
Veterinary Immunology and Immunopathology|April 1, 1988
Detection of B and T cells, with lectins or antibodies, in healthy and bovine leukemia virus-infected cattleC Fossum, A Burny, D Portetelle, et al.
Veterinary Immunology and Immunopathology|November 1, 1979
Helix pomatia a hemagglutinin, a surface marker for bovine T-lymphocytesB Morein, U Hellström, L Axelsson, et al.
Zentralblatt Fur Veterinarmedizin. Reihe B. Journal of Veterinary Medicine. Series B|June 1, 1991
ISCOM of BHV-1 envelope glycoproteins protected calves against both disease and infectionM Merza, S Tibor, L Kucsera, et al.
Vaccine|April 1, 1989
Formation and characterization of FeLV ISCOMsL Akerblom, K Strömstedt, S Hoglund, et al.
Veterinary Immunology and Immunopathology|November 1, 1996
Novel adjuvants and vaccine delivery systemsB Morein, M Villacrés-Eriksson, A Sjölander, et al.
Scandinavian Journal of Immunology|September 1, 1992
Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus iscomsM Villacres-Eriksson, M Bergström-Mollaoglu, H Kåberg, et al.
Vaccine|July 27, 1999
Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretionsJ Ekström, K F Hu, K L Bengtsson, et al.
Biotechnology Therapeutics|January 1, 1993
HIV experimental vaccines based on the iscom technology using envelope and GAG gene productsL Akerblom, P Nara, N Dunlop, et al.
Vaccine|December 31, 1997
Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicityB Rönnberg, M Fekadu, S Behboudi, et al.
Pageof 17